Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
BMC Cancer
|
May 4, 2021
Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring
Yoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial
Emily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2023
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
Shankar Siva, Pitchaya Sakyanun, Tao Mai, et al.
BMC Cancer
|
October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
Shankar Siva, Brent Chesson, Mathias Bressel, et al.
The Lancet. Respiratory Medicine
|
March 15, 2024
Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial
Daniel P Steinfort, Gargi Kothari, Neil Wallace, et al.
The Lancet. Oncology
|
May 17, 2026
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
Shankar Siva, Muhammad Ali, Nicholas Hardcastle, et al.
JAMA Oncology
|
August 29, 2021
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
Shankar Siva, Mathias Bressel, Tao Mai, et al.
Medical Physics
|
August 26, 2019
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial
Emily A Hewson, Doan Trang Nguyen, Ricky O'Brien, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial
Paul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2013
Multi-institutional quantitative evaluation and clinical validation of Smart Probabilistic Image Contouring Engine (SPICE) autosegmentation of target structures and normal tissues on computer tomography images in the head and neck, thorax, liver, and male pelvis areas
Mingyao Zhu, Karl Bzdusek, Carsten Brink, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
BMC Cancer
|
May 4, 2021
Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring
Yoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial
Emily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2023
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
Shankar Siva, Pitchaya Sakyanun, Tao Mai, et al.
BMC Cancer
|
October 25, 2018
TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II
Shankar Siva, Brent Chesson, Mathias Bressel, et al.
The Lancet. Respiratory Medicine
|
March 15, 2024
Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial
Daniel P Steinfort, Gargi Kothari, Neil Wallace, et al.
The Lancet. Oncology
|
May 17, 2026
Ultra-hypofractionated stereotactic ablative body radiotherapy for primary renal cell carcinoma: 5-year outcomes from a pooled analysis of the FASTRACK trials
Shankar Siva, Muhammad Ali, Nicholas Hardcastle, et al.
JAMA Oncology
|
August 29, 2021
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
Shankar Siva, Mathias Bressel, Tao Mai, et al.
Medical Physics
|
August 26, 2019
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trial
Emily A Hewson, Doan Trang Nguyen, Ricky O'Brien, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2020
Real-Time Image Guided Ablative Prostate Cancer Radiation Therapy: Results From the TROG 15.01 SPARK Trial
Paul Keall, Doan Trang Nguyen, Ricky O'Brien, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 22, 2013
Multi-institutional quantitative evaluation and clinical validation of Smart Probabilistic Image Contouring Engine (SPICE) autosegmentation of target structures and normal tissues on computer tomography images in the head and neck, thorax, liver, and male pelvis areas
Mingyao Zhu, Karl Bzdusek, Carsten Brink, et al.
Page
of 18